Format
Sort by
Items per page

Send to

Choose Destination

Best matches for PFKFB3 and Vascular:

Search results

Items: 1 to 20 of 38

1.

PFKFB3-mediated endothelial glycolysis promotes pulmonary hypertension.

Cao Y, Zhang X, Wang L, Yang Q, Ma Q, Xu J, Wang J, Kovacs L, Ayon RJ, Liu Z, Zhang M, Zhou Y, Zeng X, Xu Y, Wang Y, Fulton DJ, Weintraub NL, Lucas R, Dong Z, Yuan JX, Sullivan JC, Meadows L, Barman SA, Wu C, Quan J, Hong M, Su Y, Huo Y.

Proc Natl Acad Sci U S A. 2019 Jun 18. pii: 201821401. doi: 10.1073/pnas.1821401116. [Epub ahead of print]

PMID:
31213542
2.

Ablation of endothelial Pfkfb3 protects mice from acute lung injury in LPS-induced endotoxemia.

Wang L, Cao Y, Gorshkov B, Zhou Y, Yang Q, Xu J, Ma Q, Zhang X, Wang J, Mao X, Zeng X, Su Y, Verin AD, Hong M, Liu Z, Huo Y.

Pharmacol Res. 2019 Jun 2;146:104292. doi: 10.1016/j.phrs.2019.104292. [Epub ahead of print]

PMID:
31167111
3.

Andrographolide attenuates imbalance of gastric vascular homeostasis induced by ethanol through glycolysis pathway.

Yao H, Wu Z, Xu Y, Xu H, Lou G, Jiang Q, Fan W, Liu W, Zheng C, Gao Y, Wang Y.

Sci Rep. 2019 Mar 21;9(1):4968. doi: 10.1038/s41598-019-41417-5.

4.

PFKFB3 in Smooth Muscle Promotes Vascular Remodeling in Pulmonary Arterial Hypertension.

Kovacs L, Cao Y, Han W, Meadows L, Kovacs-Kasa A, Kondrikov D, Verin AD, Barman SA, Dong Z, Huo Y, Su Y.

Am J Respir Crit Care Med. 2019 Feb 28. doi: 10.1164/rccm.201812-2290OC. [Epub ahead of print]

PMID:
30817168
5.

Lymphotoxin-α promotes tumor angiogenesis in HNSCC by modulating glycolysis in a PFKFB3-dependent manner.

Yang JG, Wang WM, Xia HF, Yu ZL, Li HM, Ren JG, Chen G, Wang BK, Jia J, Zhang W, Zhao YF.

Int J Cancer. 2019 Feb 20. doi: 10.1002/ijc.32221. [Epub ahead of print]

PMID:
30785217
6.

Metabolic Pathways Fueling the Endothelial Cell Drive.

Li X, Kumar A, Carmeliet P.

Annu Rev Physiol. 2019 Feb 10;81:483-503. doi: 10.1146/annurev-physiol-020518-114731.

PMID:
30742787
7.

Smooth Muscle Contact Drives Endothelial Regeneration by BMPR2-Notch1-Mediated Metabolic and Epigenetic Changes.

Miyagawa K, Shi M, Chen PI, Hennigs JK, Zhao Z, Wang M, Li CG, Saito T, Taylor S, Sa S, Cao A, Wang L, Snyder MP, Rabinovitch M.

Circ Res. 2019 Jan 18;124(2):211-224. doi: 10.1161/CIRCRESAHA.118.313374.

PMID:
30582451
8.

Role of miRNAs in skeletal muscle aging.

Zheng Y, Kong J, Li Q, Wang Y, Li J.

Clin Interv Aging. 2018 Nov 22;13:2407-2419. doi: 10.2147/CIA.S169202. eCollection 2018.

9.

The Glycolytic Enzyme PFKFB3 Controls TNF-α-Induced Endothelial Proinflammatory Responses.

Zhang R, Li R, Liu Y, Li L, Tang Y.

Inflammation. 2019 Feb;42(1):146-155. doi: 10.1007/s10753-018-0880-x.

PMID:
30171427
10.

Effect of microRNA-26a on vascular endothelial cell injury caused by lower extremity ischemia-reperfusion injury through the AMPK pathway by targeting PFKFB3.

Wu Y, Zhang MH, Xue Y, Zhang T, Wu N, Guo W, Du X, Xu YL.

J Cell Physiol. 2019 Mar;234(3):2916-2928. doi: 10.1002/jcp.27108. Epub 2018 Aug 21.

PMID:
30132885
11.

Glycosylation as new pharmacological strategies for diseases associated with excessive angiogenesis.

Bousseau S, Vergori L, Soleti R, Lenaers G, Martinez MC, Andriantsitohaina R.

Pharmacol Ther. 2018 Nov;191:92-122. doi: 10.1016/j.pharmthera.2018.06.003. Epub 2018 Jun 29. Review.

PMID:
29909237
12.

PFKFB3 is involved in breast cancer proliferation, migration, invasion and angiogenesis.

Peng F, Li Q, Sun JY, Luo Y, Chen M, Bao Y.

Int J Oncol. 2018 Mar;52(3):945-954. doi: 10.3892/ijo.2018.4257. Epub 2018 Jan 30.

PMID:
29393396
13.

Angiogenesis revisited from a metabolic perspective: role and therapeutic implications of endothelial cell metabolism.

Draoui N, de Zeeuw P, Carmeliet P.

Open Biol. 2017 Dec;7(12). pii: 170219. doi: 10.1098/rsob.170219. Review.

14.

Endothelial specific SIRT3 deletion impairs glycolysis and angiogenesis and causes diastolic dysfunction.

He X, Zeng H, Chen ST, Roman RJ, Aschner JL, Didion S, Chen JX.

J Mol Cell Cardiol. 2017 Nov;112:104-113. doi: 10.1016/j.yjmcc.2017.09.007. Epub 2017 Sep 19.

15.

Tumor vessel disintegration by maximum tolerable PFKFB3 blockade.

Conradi LC, Brajic A, Cantelmo AR, Bouché A, Kalucka J, Pircher A, Brüning U, Teuwen LA, Vinckier S, Ghesquière B, Dewerchin M, Carmeliet P.

Angiogenesis. 2017 Nov;20(4):599-613. doi: 10.1007/s10456-017-9573-6. Epub 2017 Sep 5.

PMID:
28875379
16.

Flow-Responsive Vascular Endothelial Growth Factor Receptor-Protein Kinase C Isoform Epsilon Signaling Mediates Glycolytic Metabolites for Vascular Repair.

Baek KI, Li R, Jen N, Choi H, Kaboodrangi A, Ping P, Liem D, Beebe T, Hsiai TK.

Antioxid Redox Signal. 2018 Jan 1;28(1):31-43. doi: 10.1089/ars.2017.7044. Epub 2017 Sep 21.

17.

A role for PFKFB3/iPFK2 in metformin suppression of adipocyte inflammatory responses.

Qi T, Chen Y, Li H, Pei Y, Woo SL, Guo X, Zhao J, Qian X, Awika J, Huo Y, Wu C.

J Mol Endocrinol. 2017 Jul;59(1):49-59. doi: 10.1530/JME-17-0066.

18.

The Glycolytic Enzyme PFKFB3 Is Involved in Estrogen-Mediated Angiogenesis via GPER1.

Trenti A, Tedesco S, Boscaro C, Ferri N, Cignarella A, Trevisi L, Bolego C.

J Pharmacol Exp Ther. 2017 Jun;361(3):398-407. doi: 10.1124/jpet.116.238212. Epub 2017 Mar 27.

PMID:
28348059
19.

Endothelial cell metabolism: an update anno 2017.

Teuwen LA, Draoui N, Dubois C, Carmeliet P.

Curr Opin Hematol. 2017 May;24(3):240-247. doi: 10.1097/MOH.0000000000000335. Review.

PMID:
28212191
20.

To PFKFB3 or Not to PFKFB3, That Is the Question.

Branco C, Johnson RS.

Cancer Cell. 2016 Dec 12;30(6):831. doi: 10.1016/j.ccell.2016.11.007.

Supplemental Content

Loading ...
Support Center